Logo

Almac Diagnostics Licenses GeneGo's MetaCore

Dec 27, 2006
NEW YORK (GenomeWeb News) - GeneGo said last week that Almac Diagnostics, a division of Almac Group, has licensed its MetaCore data-mining platform.
 
Almac Diagnostics will use MetaCore to help develop its microarray-based products diagnosing and treating cancer.
 
The company will also use the platform in its genomic services division.
 
"We compared several platforms before we finally decided on GeneGo,” said Vitali Proutski, bioinformatics manager at Almac Diagnostics, in a statement.
 
Financial terms of the agreement were not provided.

Filed under

Informatics
Microarrays & Multiplexing
microarrays
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.